Hyperfine, Inc. (HYPR) News
Filter HYPR News Items
HYPR News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
HYPR News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest HYPR News From Around the Web
Below are the latest news stories about HYPERFINE INC that investors may wish to consider to help them evaluate HYPR as an investment opportunity.
NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business UpdatesPreliminary unaudited revenue expected to be between $21.0 million and $21.5 million for Q4 2024, and between $79.4 million and $79.9 million for full year 2024 Scott Huennekens Appointed to NeuroPace Board of Directors effective January 6th Management presenting at the 43rd Annual J.P. Morgan Healthcare Conference on January 15th Company to host an Investor Day on January 28th in New York City MOUNTAIN VIEW, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical dev |
CytoMed Therapeutics Leads 3 US Penny Stocks To ConsiderAs the U.S. equities market begins 2025 on a challenging note, extending its recent slump, investors are keenly observing potential opportunities amid broader market declines. Penny stocks, despite their vintage moniker, continue to attract attention for those interested in smaller or newer companies with potential value. This article explores three penny stocks that stand out for their financial strength and balance sheet resilience, offering intriguing possibilities for investors seeking... |
Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern MarketsGUILFORD, Conn., December 17, 2024--Hyperfine, Inc. announces global expansion of commercial operations into Turkey, Israel and Saudi Arabia to support Swoop® system expansion plans. |
Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of CareGUILFORD, Conn., December 05, 2024--Hyperfine highlights data and conclusions from eleven abstracts presented at the Radiological Society of North America 2024 Annual Meeting in Chicago. |
Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business VerticalsGUILFORD, Conn., December 03, 2024--Strategic appointments position Hyperfine to drive the adoption of the Swoop® system in hospital settings and expand into the office setting |
US Penny Stocks To Consider In November 2024As the U.S. stock market experiences a rise, with major indexes on track for weekly gains and Bitcoin reaching new all-time highs, investors are exploring diverse opportunities in various segments. Penny stocks, despite being an older term, continue to attract interest due to their potential for value and growth that larger firms might overlook. This article will explore three penny stocks with strong financials that could offer stability and upside potential for investors interested in... |
Hyperfine Swoop® Portable MR Brain Imaging System Meets New Standards Recently Issued by CMS-Approved Accrediting BodyGUILFORD, Conn., November 21, 2024--The new MRI standards by the IAC, effective immediately, now include portable MR scanning at the point of care. |
Hyperfine Announces Ten Abstracts at RSNA, Highlighting the Expanding Utility and Potential of Portable MR Brain Imaging in Diverse Clinical and Research SettingsGUILFORD, Conn., November 19, 2024--Hyperfine, Inc. announces ten scientific abstracts highlighting ultra-low-field imaging will be presented at the RSNA 2024 Annual Meeting. |
Hyperfine Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS In LineHyperfine ( NASDAQ:HYPR ) Third Quarter 2024 Results Key Financial Results Revenue: US$3.64m (up 56% from 3Q 2023). Net... |
Is Hyperfine (NASDAQ:HYPR) In A Good Position To Invest In Growth?Just because a business does not make any money, does not mean that the stock will go down. For example, although... |